መነሻ › የእንቁላል ካንሰር › Ohio › Columbus
በColumbus፣ OH ለየእንቁላል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየእንቁላል ካንሰር የሚደረጉ 39 ጥናቶች በColumbus እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Ohio State University Comprehensive Cancer Center, Columbus
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- እና 13 ተጨማሪ
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Columbus
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The Mark H Zangmeister Center /ID# 275106, Columbus
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Site 0243 - Mark H Zangmeister Cancer Center, Columbus
- Site 0214-Ohio State University Comprehensive Cancer Center, Hilliard · 10 ማይል ርቀት
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The Ohio State University Wexner Medical Center, Columbus
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The Ohio State University Wexner Medical Center, Columbus
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Research Site, Columbus
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- The Mark H Zangmeister Center, Columbus
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Hilliard · 10 ማይል ርቀት
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Jamescare Gynecologic Oncology At Mill Run /ID# 277951, Hilliard · 10 ማይል ርቀት
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Ohio Health Research Institute, Columbus
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The Mark H Zangmeister Cancer Center Ohio, Columbus
- The Ohio State University Wexner Medical Center Division of Gynecologic Oncology, Hilliard · 10 ማይል ርቀት
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The Ohio State University Comprehensive Cancer Center, Hilliard · 10 ማይል ርቀት
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Ohio State University, Columbus
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Zangmeister Cancer Center, Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0054), Columbus
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- OhioHealth Research Institute, Columbus
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The Ohio State University, Columbus
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Ohio State University Wexner Medical Center, Columbus
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
- Ohio State University Comprehensive Cancer Center, Columbus
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The Ohio State University, Columbus
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Site 0108, Columbus
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
ተሳታዮችን በመፈለግ ላይ
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- እና 8 ተጨማሪ
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- እና 8 ተጨማሪ
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Ohio State University Wexner Medical Center, Hilliard · 10 ማይል ርቀት
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Ohio State University, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Lead-212 PSV359 Therapy for Patients With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The James Cancer Hospital and Solove Research Institute - Ohio State University, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Columbus
በሌሎች ከተሞች ለየእንቁላል ካንሰር የሚደረጉ ጥናቶች
- Houston, TX89 ጥናቶች
- New York City, NY69 ጥናቶች
- Boston, MA61 ጥናቶች
- Los Angeles, CA50 ጥናቶች
- Nashville, TN49 ጥናቶች
- Arlington, VA46 ጥናቶች
- Philadelphia, PA44 ጥናቶች
- St. Louis, MO38 ጥናቶች
- Chicago, IL36 ጥናቶች
- San Antonio, TX31 ጥናቶች
- Cleveland, OH30 ጥናቶች
- Pittsburgh, PA30 ጥናቶች
በColumbus ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር57 ጥናቶች
- የጡንቻ ካንሰር40 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)38 ጥናቶች
- የሳንባ ካንሰር37 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ35 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ28 ጥናቶች
- Metastatic Cancer27 ጥናቶች
- የኤንዶሜትሪየም ካንሰር25 ጥናቶች
- የፕሮስቴት ካንሰር24 ጥናቶች
- Multiple Myeloma24 ጥናቶች
- የኮሎሬክታል ካንሰር24 ጥናቶች
- ሜላኖማ21 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።